Correlation Between GlaxoSmithKline PLC and IShares MSCI

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and IShares MSCI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and IShares MSCI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and iShares MSCI USA, you can compare the effects of market volatilities on GlaxoSmithKline PLC and IShares MSCI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of IShares MSCI. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and IShares MSCI.

Diversification Opportunities for GlaxoSmithKline PLC and IShares MSCI

-0.87
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GlaxoSmithKline and IShares is -0.87. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and iShares MSCI USA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares MSCI USA and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with IShares MSCI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares MSCI USA has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and IShares MSCI go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and IShares MSCI

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the IShares MSCI. In addition to that, GlaxoSmithKline PLC is 1.8 times more volatile than iShares MSCI USA. It trades about -0.23 of its total potential returns per unit of risk. iShares MSCI USA is currently generating about 0.42 per unit of volatility. If you would invest  11,800  in iShares MSCI USA on September 1, 2024 and sell it today you would earn a total of  760.00  from holding iShares MSCI USA or generate 6.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  iShares MSCI USA

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
iShares MSCI USA 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in iShares MSCI USA are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile essential indicators, IShares MSCI may actually be approaching a critical reversion point that can send shares even higher in December 2024.

GlaxoSmithKline PLC and IShares MSCI Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and IShares MSCI

The main advantage of trading using opposite GlaxoSmithKline PLC and IShares MSCI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, IShares MSCI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares MSCI will offset losses from the drop in IShares MSCI's long position.
The idea behind GlaxoSmithKline PLC ADR and iShares MSCI USA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets